| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110282 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 06/10/2004 | US20040110263 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110164 L-methionine $g(g)-lyase with modified function |
| 06/10/2004 | US20040109907 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 06/10/2004 | US20040109865 Antibody composition-containing medicament |
| 06/10/2004 | US20040109858 Conformation-specific anti-von Willebrand factor antibodies |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | US20040109843 Pharmaceutical composition containing decoy and use of the same |
| 06/10/2004 | CA2507616A1 Highly stable pacap/vip-derived peptides |
| 06/10/2004 | CA2507026A1 Imidazole derivatives, their production and use |
| 06/10/2004 | CA2506948A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 06/10/2004 | CA2506799A1 Mixed lineage kinase modulators |
| 06/10/2004 | CA2506796A1 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 06/10/2004 | CA2506490A1 Peptide gap junction modulators |
| 06/10/2004 | CA2506310A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 06/10/2004 | CA2505524A1 Novel use of erythropoietin in heart diseases |
| 06/10/2004 | CA2502614A1 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 06/09/2004 | EP1426762A1 Remedies for heart diseases |
| 06/09/2004 | EP1426055A1 Targeted protein degradation vehicles (tpdvs), nucleic acid constructs encoding them and their use |
| 06/09/2004 | EP1426051A1 Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy |
| 06/09/2004 | EP1426050A1 Jnk inhibitors |
| 06/09/2004 | EP1426046A1 Novel use of tricyclic compound |
| 06/09/2004 | EP1425388A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 06/09/2004 | EP1425308A2 Polysaccharidic esters of retinoic acid |
| 06/09/2004 | EP1425306A2 Nanoparticles comprising biologically active tnf which is immobilised on the same |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425283A1 Novel 4-aminofuropyrimidines and the use thereof |
| 06/09/2004 | EP1425281A1 Chemical compounds |
| 06/09/2004 | EP1425280A2 Hetero-bicyclic crf antagonists |
| 06/09/2004 | EP1425277A2 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/09/2004 | EP1425265A1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1425042A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425031A2 Hdl for the treatment of stroke and other ischemic conditions |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425029A1 Peptidomimetics of biologically active metallopeptides |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425018A1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof |
| 06/09/2004 | EP1425014A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 06/09/2004 | EP1425010A1 Substituted indoles and their use as integrin antagonists |
| 06/09/2004 | EP1425007A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | EP1425000A1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity |
| 06/09/2004 | EP1424999A1 Use of c2-substituted indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424994A1 Preparation of sustained release pharmaceutical composition |
| 06/09/2004 | EP1424907A1 Oil composition |
| 06/09/2004 | EP1267917A4 Angiogenic onchocerca volvulus proteins and uses thereof |
| 06/09/2004 | EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 06/09/2004 | EP1235797B1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 06/09/2004 | EP1212323B1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/09/2004 | EP1196176B1 Use of beta-napthoquinone derivatives for the manufacture of a medicament having an inhibiting effect on the release of glutamate by the brain |
| 06/09/2004 | EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin |
| 06/09/2004 | EP1171441B1 Morphinoid compounds |
| 06/09/2004 | EP0892786B1 New carboxylic acid derivatives, their production and use |
| 06/09/2004 | CN1503800A antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 06/09/2004 | CN1503797A Pyridopyrimidine or naphthyridine derivative |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503786A Large conductance calcium-activated k channel opener |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1503672A 6-substituted pyrido-pyrimidines |
| 06/09/2004 | CN1503667A Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 06/09/2004 | CN1502628A Polyglycol modification article for acidic fibroblast growth factor and its mutant |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502608A Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity |
| 06/09/2004 | CN1502370A Composition for cooperative therapy and method thereof |
| 06/09/2004 | CN1502359A Prunella spike oral liquid and preparation process thereof |
| 06/09/2004 | CN1502356A Blood pressure reducing health care incense and preparation method thereof |
| 06/09/2004 | CN1502345A Medicine for treating paralysis disease |
| 06/09/2004 | CN1502341A Process for preparing novel traditional Chinese medicine-compound salvia dispersion tablet |
| 06/09/2004 | CN1502340A Process for prepaing ginkgo leaf dispersion tablet |
| 06/09/2004 | CN1502337A Oral medicine for treating cardio-cerebral vascular disease and preparation process thereof |
| 06/09/2004 | CN1502336A Application of Astragalosides in preparation of medicine for treating viral myocarditis |
| 06/09/2004 | CN1502333A Slow released table of captopril |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1152886C Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152864C Phenylphenanthridines with PDE-IV inhibiting activity |
| 06/09/2004 | CN1152708C Granular medicine for treating stagnancy of qi and blood stasis type cardio-cerebro vascular disease and its preparing process |
| 06/09/2004 | CN1152702C Chinese mecdicine for treating bone tuberculosis, osteomyelitis phlebitis and organism ulceration |
| 06/09/2004 | CN1152685C Usage of endothelin receptor agonist in preparation of medicine for treating obesity |
| 06/09/2004 | CN1152683C Medicinal composition containing naphthyl compound |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6747132 Methods for the synthesis of a modified hemoglobin solution |
| 06/08/2004 | US6747061 N-substituted dithiocarbamates for the treatment of biological disorders |
| 06/08/2004 | US6747056 K99-5041 substance and production thereof |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747049 Oxazole derivatives |
| 06/08/2004 | US6747043 Alkoxy aryl β2 adrenergic receptor agonists |
| 06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |